Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02229227
What this trial is testing

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 814
Post-approval studies (Phase 4)Study completedNCT01695109
What this trial is testing

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Who this might be right for
Healthy Human Male Subjects
Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT02315001
What this trial is testing

Liraglutide to Improve corONary Haemodynamics During Exercise streSS

Who this might be right for
Ischaemic Heart DiseaseCoronary Heart DiseaseChronic Stable Angina
King's College London 26
Not applicableActive Not RecruitingNCT06234111
What this trial is testing

Semaglutide and Physical Activity for Obesity and Multimorbidity

Who this might be right for
Obesity MorbidMultimorbidityObesity
Hvidovre University Hospital 35
Not applicableStudy completedNCT03498001
What this trial is testing

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

Who this might be right for
Type II Diabetes
Centre Hospitalier Universitaire Dijon 42
Not applicableStudy completedNCT07448519
What this trial is testing

Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity

Who this might be right for
Obesity & OverweightAppetite Regulation
Queen Mary University of London 20
Not applicableStudy completedNCT07774208
What this trial is testing

FABP4 Response After Roux-en-Y Gastric Bypass

Who this might be right for
Obesity (BMI>30)Obesity (BMI > 35)Insulin Resistance+2 more
Istanbul University 28
Post-approval studies (Phase 4)Looking for participantsNCT06606821
What this trial is testing

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseCoronary Microvascular DysfunctionOverweight or Obesity+3 more
Tina Vilsbøll 124
Not applicableStudy completedNCT02442791
What this trial is testing

GLP-1 Analogs for Neuroprotection After Cardiac Arrest

Who this might be right for
Cardiac ArrestComa
Jesper Kjaergaard 120
Early research (Phase 1)Study completedNCT00551590
What this trial is testing

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ludwig-Maximilians - University of Munich 24
Early research (Phase 1)Study completedNCT01304823
What this trial is testing

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

Who this might be right for
Taste Disorder, Primary, Sweet
University Hospital, Basel, Switzerland 10
Post-approval studies (Phase 4)Study completedNCT02291874
What this trial is testing

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 100
Large-scale testing (Phase 3)UnknownNCT02718950
What this trial is testing

Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

Who this might be right for
ObesityType 2 Diabetes Mellitus
University of Campinas, Brazil 20
Not applicableUnknownNCT04862858
What this trial is testing

Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
Humana Inc. 4,197
Early research (Phase 1)Not Yet RecruitingNCT07550621
What this trial is testing

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

Who this might be right for
Healthy Volunteers (HV)
MindRank AI Ltd 28
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Not applicableLooking for participantsNCT07207148
What this trial is testing

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Who this might be right for
Multiple Sclerosis
Northwestern University 100
Not applicableStudy completedNCT01473147
What this trial is testing

Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Chang Gung Memorial Hospital 51
Post-approval studies (Phase 4)Study completedNCT00885638
What this trial is testing

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Who this might be right for
HealthyType 2 Diabetes
Lund University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07502508
What this trial is testing

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Who this might be right for
Type 2 Diabetes
Biomea Fusion Inc. 60
Next Page